Type
. In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin. PloS one [Internet]. 2017;12(5):e0177815. Available from: http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0177815&type=printable
Type
. In silico finding of the putative drug targets from hypothetical set of proteins for Mycobacterium leprae TN. International journal of pharmaceutical sciences and research [Internet]. 2017;8(5):2100-2121. Available from: http://tinyurl.com/mvyje35
Type
. A population based survey to assess the scenario of leprosy in a high endemic block in south Tamilnadu. International Journal of Health Sciences and Research [Internet]. 2016;6(8):61-65. Available from: http://www.scopemed.org/fulltextpdf.php?mno=238391
Type
. Spatial and temporal epidemiology of Mycobacterium leprae infection among leprosy patients and household contacts of an endemic region in Southeast Brazil. Acta tropica. 2016;163:38-45.
Type
. [In memory of Dr. Joon Lew]. Nihon Hansenbyō Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2016;84(3):113-4.
Type
. [On the present and future of National Sanatorium Tohokushinseien]. Nihon Hansenbyō Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association [Internet]. 2015;84(2):71-2. Available from: https://www.jstage.jst.go.jp/article/hansen/84/2/84_71/_pdf
Type
. A case of subcutaneous phaeohyphomycosis associated with leprosy. Infectious disorders drug targets. 2017;.
Type
. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature. Dermatologic therapy. 2016;.
Type
. Phenotypic, molecular and pathogenic characterization of Phlyctema vagabunda, causal agent of olive leprosy. Plant pathology. 2017;.
Type
. Likelihood of achieving WHO leprosy goals: An expert survey. [Ann Arbor]: Yale University; 2016. p. 30 p.